EFFECTOR To Wind Down Operations; Expects Securities To Be Delisted
(RTTNews) - eFFECTOR Therapeutics (EFTR) has terminated its employees and will wind down operations, including seeking potential strategic alternatives for the company's development programs. The decision was made at a special meeting of the board. Also, the company plans to voluntarily request a delisting of its securities and expects its securities to be delisted in the near term.
The board appointed Craig Jalbert as the company's CEO, President, Treasurer and Secretary, and sole member of the board. Jalbert has served as a principal of the Foxborough, Massachusetts accounting firm of Verdolino & Lowey, P.C.
Shares of eFFECTOR are down 65% in pre-market trade on Monday.
For More Such Health News, visit rttnews.com.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.